Deals17 Oct 2025, 05:31 pm
Ipca Laboratories to Sell Ankleshwar Manufacturing Unit for Rs. 22.15 Crores
AI Summary
Ipca Laboratories Ltd. has approved the sale of its drug intermediates and active pharmaceutical ingredients (APIs) manufacturing unit situated at GIDC Industrial Estate, Ankleshwar, Gujarat, to M/s. Suleshvari Pharma Private Ltd. for a consideration of Rs. 22.15 crores. The sale is part of the company's operational strategy to reduce the number of manufacturing units and minimize operational and other costs. The manufacturing unit contributed 0.74% of the total income of the company in the financial year ended 31st March, 2025. The sale is expected to be completed by 31st December, 2025, subject to necessary consents.
Key Highlights
- Ipca Laboratories to sell its manufacturing unit in Ankleshwar to M/s. Suleshvari Pharma Private Ltd.
- The deal is worth Rs. 22.15 crores.
- The sale is part of the company's operational strategy to reduce costs.
- The manufacturing unit contributed 0.74% of the company's total income in FY 2024-25.
- The sale is expected to be completed by 31st December, 2025.